Cargando…
Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background
A wide range of viruses cause neurological manifestations in their hosts. Infection by neurotropic viruses as well as the resulting immune response can irreversibly disrupt the complex structural and functional architecture of the brain, depending in part on host genetic background. The interaction...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501595/ https://www.ncbi.nlm.nih.gov/pubmed/36142395 http://dx.doi.org/10.3390/ijms231810482 |
_version_ | 1784795513598509056 |
---|---|
author | Lawley, Koedi S. Rech, Raquel R. Perez Gomez, Aracely A. Hopkins, Laura Han, Gang Amstalden, Katia Welsh, C. Jane Young, Colin R. Jones-Hall, Yava Threadgill, David W. Brinkmeyer-Langford, Candice L. |
author_facet | Lawley, Koedi S. Rech, Raquel R. Perez Gomez, Aracely A. Hopkins, Laura Han, Gang Amstalden, Katia Welsh, C. Jane Young, Colin R. Jones-Hall, Yava Threadgill, David W. Brinkmeyer-Langford, Candice L. |
author_sort | Lawley, Koedi S. |
collection | PubMed |
description | A wide range of viruses cause neurological manifestations in their hosts. Infection by neurotropic viruses as well as the resulting immune response can irreversibly disrupt the complex structural and functional architecture of the brain, depending in part on host genetic background. The interaction between host genetic background, neurological response to viral infection, and subsequent clinical manifestations remains poorly understood. In the present study, we used the genetically diverse Collaborative Cross (CC) mouse resource to better understand how differences in genetic background drive clinical signs and neuropathological manifestations of acute Theiler’s murine encephalomyelitis virus (TMEV) infection. For the first time, we characterized variations of TMEV viral tropism and load based on host genetic background, and correlated viral load with microglial/macrophage activation. For five CC strains (CC002, CC023, CC027, CC057, and CC078) infected with TMEV, we compared clinical signs, lesion distribution, microglial/macrophage response, expression, and distribution of TMEV mRNA, and identified genetic loci relevant to the early acute (4 days post-infection [dpi]) and late acute (14 dpi) timepoints. We examined brain pathology to determine possible causes of strain-specific differences in clinical signs, and found that fields CA1 and CA2 of the hippocampal formation were especially targeted by TMEV across all strains. Using Iba-1 immunolabeling, we identified and characterized strain- and timepoint-specific variation in microglial/macrophage reactivity in the hippocampal formation. Because viral clearance can influence disease outcome, we used RNA in situ hybridization to quantify viral load and TMEV mRNA distribution at both timepoints. TMEV mRNA expression was broadly distributed in the hippocampal formation at 4 dpi in all strains but varied between radiating and clustered distribution depending on the CC strain. We found a positive correlation between microglial/macrophage reactivity and TMEV mRNA expression at 4 dpi. At 14 dpi, we observed a dramatic reduction in TMEV mRNA expression, and localization to the medial portion of field CA1 and field CA2. To better understand how host genetic background can influence pathological outcomes, we identified quantitative trait loci associated with frequency of lesions in a particular brain region and with microglial/macrophage reactivity. These QTL were located near several loci of interest: lysosomal trafficking regulator (Lyst) and nidogen 1 (Nid1), and transmembrane protein 106 B (Tmem106b). Together, these results provide a novel understanding about the influences of genetic variation on the acute neuropathological and immunopathological environment and viral load, which collectively lead to variable disease outcomes. Our findings reveal possible avenues for future investigation which may lead to more effective intervention strategies and treatment regimens. |
format | Online Article Text |
id | pubmed-9501595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95015952022-09-24 Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background Lawley, Koedi S. Rech, Raquel R. Perez Gomez, Aracely A. Hopkins, Laura Han, Gang Amstalden, Katia Welsh, C. Jane Young, Colin R. Jones-Hall, Yava Threadgill, David W. Brinkmeyer-Langford, Candice L. Int J Mol Sci Article A wide range of viruses cause neurological manifestations in their hosts. Infection by neurotropic viruses as well as the resulting immune response can irreversibly disrupt the complex structural and functional architecture of the brain, depending in part on host genetic background. The interaction between host genetic background, neurological response to viral infection, and subsequent clinical manifestations remains poorly understood. In the present study, we used the genetically diverse Collaborative Cross (CC) mouse resource to better understand how differences in genetic background drive clinical signs and neuropathological manifestations of acute Theiler’s murine encephalomyelitis virus (TMEV) infection. For the first time, we characterized variations of TMEV viral tropism and load based on host genetic background, and correlated viral load with microglial/macrophage activation. For five CC strains (CC002, CC023, CC027, CC057, and CC078) infected with TMEV, we compared clinical signs, lesion distribution, microglial/macrophage response, expression, and distribution of TMEV mRNA, and identified genetic loci relevant to the early acute (4 days post-infection [dpi]) and late acute (14 dpi) timepoints. We examined brain pathology to determine possible causes of strain-specific differences in clinical signs, and found that fields CA1 and CA2 of the hippocampal formation were especially targeted by TMEV across all strains. Using Iba-1 immunolabeling, we identified and characterized strain- and timepoint-specific variation in microglial/macrophage reactivity in the hippocampal formation. Because viral clearance can influence disease outcome, we used RNA in situ hybridization to quantify viral load and TMEV mRNA distribution at both timepoints. TMEV mRNA expression was broadly distributed in the hippocampal formation at 4 dpi in all strains but varied between radiating and clustered distribution depending on the CC strain. We found a positive correlation between microglial/macrophage reactivity and TMEV mRNA expression at 4 dpi. At 14 dpi, we observed a dramatic reduction in TMEV mRNA expression, and localization to the medial portion of field CA1 and field CA2. To better understand how host genetic background can influence pathological outcomes, we identified quantitative trait loci associated with frequency of lesions in a particular brain region and with microglial/macrophage reactivity. These QTL were located near several loci of interest: lysosomal trafficking regulator (Lyst) and nidogen 1 (Nid1), and transmembrane protein 106 B (Tmem106b). Together, these results provide a novel understanding about the influences of genetic variation on the acute neuropathological and immunopathological environment and viral load, which collectively lead to variable disease outcomes. Our findings reveal possible avenues for future investigation which may lead to more effective intervention strategies and treatment regimens. MDPI 2022-09-09 /pmc/articles/PMC9501595/ /pubmed/36142395 http://dx.doi.org/10.3390/ijms231810482 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lawley, Koedi S. Rech, Raquel R. Perez Gomez, Aracely A. Hopkins, Laura Han, Gang Amstalden, Katia Welsh, C. Jane Young, Colin R. Jones-Hall, Yava Threadgill, David W. Brinkmeyer-Langford, Candice L. Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title | Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title_full | Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title_fullStr | Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title_full_unstemmed | Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title_short | Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background |
title_sort | viral clearance and neuroinflammation in acute tmev infection vary by host genetic background |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501595/ https://www.ncbi.nlm.nih.gov/pubmed/36142395 http://dx.doi.org/10.3390/ijms231810482 |
work_keys_str_mv | AT lawleykoedis viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT rechraquelr viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT perezgomezaracelya viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT hopkinslaura viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT hangang viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT amstaldenkatia viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT welshcjane viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT youngcolinr viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT joneshallyava viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT threadgilldavidw viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground AT brinkmeyerlangfordcandicel viralclearanceandneuroinflammationinacutetmevinfectionvarybyhostgeneticbackground |